Business Background
EYWA is a biotechnology startup focused on transforming mental healthcare through the development of patient-centered treatments powered by biosynthesis and psychedelic medicine. With a vision centered on accessibility and innovation, the company is building new approaches to mental health therapies using adaptogenic and hallucinogenic mushroom microdosing.
As part of this mission, EYWA sought a strategic technology partner to support the development of a two-sided digital platform designed for both patients and practitioners. The platform aimed to provide treatment tracking, monitoring, and follow-up tools in a secure and scalable environment tailored to psychedelic-assisted therapies.
Get your solutionBusiness Goals
Following a successful Product Discovery phase, EYWA’s main objective was to develop a fast, cost-efficient MVP capable of validating the platform with real users in a production-ready environment. The company needed to transform discovery insights into a functional product that could support psychologists, psychiatrists, and patients throughout treatment workflows.
The platform needed to combine usability, scalability, and secure patient data handling while delivering the core features necessary for early market validation. At the same time, the team had to prioritize development carefully in order to launch an effective MVP within a limited timeframe and budget.
Solution
To support the MVP execution, The Flock assembled a specialized product and engineering team that included a Product Manager, Business Analyst, Full-stack Developers, and Quality Assurance specialists. Working closely with EYWA’s stakeholders, the team followed an agile development approach focused on rapid iteration and continuous collaboration.
Using technologies such as React.js, Rails, Material-UI, TailwindCSS, and data visualization tools like D3.js and Chart.js, the team developed the platform’s core functionalities, including practitioner and patient workflows, treatment tracking features, and monitoring capabilities tailored to psychedelic-assisted therapies. The collaboration allowed the product to evolve efficiently while maintaining alignment with EYWA’s long-term vision.
Software solutions we offered: MVP Development: Product Strategy, Full-stack Development, Patient Workflows & Treatment Tracking..
Results
The MVP execution resulted in a functional platform that enabled EYWA to begin validating its solution with real users while significantly reducing development risks and time-to-market. The successful launch provided the company with an initial production-ready environment capable of supporting treatment tracking and engagement workflows for both practitioners and patients.
The project also established a strong technological and operational foundation for future product evolution. By launching quickly and gathering real-world feedback, EYWA was able to continue refining the platform based on user adoption and behavioral insights, positioning the company to keep innovating within the emerging mental health and psychedelic treatment space.
Get your solution
